Autres langues BG Medicine, Inc.

Actions

BGMD

US08861T2069

Marché Fermé - OTC Markets Autres places de cotation 16:36:41 06/12/2023			Varia. 5j.	Varia. 1 janv.
0,000001 ^USD	-.--%		-.--%	-.--%

2015	Transcript : BG Medicine, Inc. - Special Call
2015	Transcript : BG Medicine, Inc., Q2 2015 Earnings Call, Aug 19, 2015

Autres langues

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

BG Medicine, Inc. Reports Earnings Results for the Full Year Ended December 31, 2015	31/03/16
BG Medicine Announces Board Changes	04/02/16
BG Medicine Withdraws 510(K) Premarket Notification for Proposed Additional Indication for the Bgm Galectin-3® Test	23/12/15
BG Medicine, Inc. Amends License and Distribution Agreement for Galectin-3 with Abbott Laboratories	30/11/15
BG Medicine, Inc. Announces Board Changes	20/11/15
BG Medicine, Inc. Reports Unaudited Consolidated Earnings Results for the Third Quarter and Nine Months Ended September 30, 2015	17/11/15
Certain Options of BG Medicine, Inc. are subject to a Lock-Up Agreement Ending on 11-NOV-2015.	11/11/15
Certain Warrants of BG Medicine, Inc. are subject to a Lock-Up Agreement Ending on 11-NOV-2015.	11/11/15
Certain shares of BG Medicine, Inc.'s Common Stock are subject to a Lock-Up Agreement Ending on 11-NOV-2015.	11/11/15
Timothy Harris Resigns to Board of Directors and Audit Committee of BG Medicine, Inc	25/09/15
BG Medicine, Inc.(OTCPK:BGMD) dropped from MSCI Acwi + Frontier Markets(acwi Fm) All Cap Index	17/09/15
BG Medicine, Inc.(OTCPK:BGMD) dropped from S&P TMI Index	17/09/15
BG Medicine, Inc.(OTCPK:BGMD) dropped from CRSP US Total Market Index	16/09/15
BG Medicine, Inc.(NasdaqCM:BGMD) dropped from NASDAQ Composite Index	15/09/15
BG Medicine, Inc. Announces Unaudited Consolidated Earnings Results for the Second Quarter and Six Months Ended June 30, 2015	14/08/15
BG Medicine, Inc. Announces Payoff of Secured Term Loan	15/07/15
BG Medicine, Inc. announced that it has received $2.5 million in funding from Flagship Ventures.	14/07/15
BG Medicine, Inc. Announces First Automated Test for Galectin-3 Now Available in U.S	06/07/15
BGMD Seeks Acquisitions	19/05/15
BG Medicine, Inc. Announces Unaudited Consolidated Earnings Results for the First Quarter Ended March 31, 2015; Provides Financial Guidance for 2015	14/05/15

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Autres langues BG Medicine, Inc.

Actions

BGMD

US08861T2069

Autres langues

Filtres